91 related articles for article (PubMed ID: 22965410)
21. Is adjuvant chemotherapy really needed after curative surgery for rectal cancer patients who are node-negative after neoadjuvant chemoradiotherapy?
Kiran RP; Kirat HT; Burgess AN; Nisar PJ; Kalady MF; Lavery IC
Ann Surg Oncol; 2012 Apr; 19(4):1206-12. PubMed ID: 21935748
[TBL] [Abstract][Full Text] [Related]
22. Assessment of the inferior mesenteric vein diameter as a surrogate marker to evaluate response to neoadjuvant chemoradiotherapy for locally advanced rectal adenocarcinoma.
Ivan CV; Mullineux JH; Verma R; Shah V; De A; Elabassy M; Rajesh A; Stephenson JA
Colorectal Dis; 2017 Dec; 19(12):1076-1080. PubMed ID: 28696522
[TBL] [Abstract][Full Text] [Related]
23. Delaying surgery after neoadjuvant chemoradiotherapy in rectal cancer has no influence in surgical approach or short-term clinical outcomes.
Figueiredo N; Panteleimonitis S; Popeskou S; Cunha JF; Qureshi T; Beets GL; Heald RJ; Parvaiz A
Eur J Surg Oncol; 2018 Apr; 44(4):484-489. PubMed ID: 29398323
[TBL] [Abstract][Full Text] [Related]
24. Organ preservation for clinical T2N0 distal rectal cancer using neoadjuvant chemoradiotherapy and local excision (ACOSOG Z6041): results of an open-label, single-arm, multi-institutional, phase 2 trial.
Garcia-Aguilar J; Renfro LA; Chow OS; Shi Q; Carrero XW; Lynn PB; Thomas CR; Chan E; Cataldo PA; Marcet JE; Medich DS; Johnson CS; Oommen SC; Wolff BG; Pigazzi A; McNevin SM; Pons RK; Bleday R
Lancet Oncol; 2015 Nov; 16(15):1537-1546. PubMed ID: 26474521
[TBL] [Abstract][Full Text] [Related]
25. Comparison of oncologic outcomes of metastatic rectal cancer patients with or without neoadjuvant chemoradiotherapy.
Kim SH; Kim JH; Jung SH
Int J Colorectal Dis; 2015 Sep; 30(9):1193-9. PubMed ID: 26072129
[TBL] [Abstract][Full Text] [Related]
26. Loop ostomy following laparoscopic low anterior resection for rectal cancer after neoadjuvant chemoradiotherapy.
Wu X; Lin G; Qiu H; Xiao Y; Wu B; Zhong M
Eur J Med Res; 2018 May; 23(1):24. PubMed ID: 29788989
[TBL] [Abstract][Full Text] [Related]
27. [The treatment of rectal cancer, complicated by the intestinal obstruction].
Velibekova MCh; Kerimov AKh
Khirurgiia (Mosk); 2012; (9):75-7. PubMed ID: 23222986
[TBL] [Abstract][Full Text] [Related]
28. Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trial.
Rödel C; Graeven U; Fietkau R; Hohenberger W; Hothorn T; Arnold D; Hofheinz RD; Ghadimi M; Wolff HA; Lang-Welzenbach M; Raab HR; Wittekind C; Ströbel P; Staib L; Wilhelm M; Grabenbauer GG; Hoffmanns H; Lindemann F; Schlenska-Lange A; Folprecht G; Sauer R; Liersch T;
Lancet Oncol; 2015 Aug; 16(8):979-89. PubMed ID: 26189067
[TBL] [Abstract][Full Text] [Related]
29. Evidence-based routine use vs selective use of neoadjuvant therapy in practice: toward personalized management of advanced rectal cancer.
Penninckx F
Colorectal Dis; 2012 Jul; 14(7):795-6. PubMed ID: 22681229
[No Abstract] [Full Text] [Related]
30. Results of neoadjuvant short-course radiation therapy followed by transanal endoscopic microsurgery for t1-t2 n0 extraperitoneal rectal cancer.
Arezzo A; Arolfo S; Allaix ME; Munoz F; Cassoni P; Monagheddu C; Ricardi U; Ciccone G; Morino M
Int J Radiat Oncol Biol Phys; 2015 Jun; 92(2):299-306. PubMed ID: 25772184
[TBL] [Abstract][Full Text] [Related]
31. Histological grading based on poorly differentiated clusters is predictive of tumour response and clinical outcome in rectal carcinoma treated with neoadjuvant chemoradiotherapy.
Reggiani Bonetti L; Lionti S; Domati F; Pagliani G; Mattioli E; Barresi V
Histopathology; 2017 Sep; 71(3):393-405. PubMed ID: 28425130
[TBL] [Abstract][Full Text] [Related]
32. Rectal obstruction secondary to carcinoma of the prostate.
Fry DE; Amin M; Harbrecht PJ
Ann Surg; 1979 Apr; 189(4):488-92. PubMed ID: 443903
[TBL] [Abstract][Full Text] [Related]
33. Adjuvant treatment for locally advanced rectal cancer patients after preoperative chemoradiotherapy: when, and for whom?
De Stefano A; Moretto R; Bucci L; Pepe S; Romano FJ; Cella AC; Attademo L; Rosanova M; De Falco S; Fiore G; Raimondo L; De Placido S; Carlomagno C
Clin Colorectal Cancer; 2014 Sep; 13(3):185-91. PubMed ID: 25080847
[TBL] [Abstract][Full Text] [Related]
34. Long-term prognostic value of mesorectal grading after neoadjuvant chemoradiotherapy for rectal cancer.
Madbouly KM; Hussein AM; Abdelzaher E
Am J Surg; 2014 Sep; 208(3):332-41. PubMed ID: 24581995
[TBL] [Abstract][Full Text] [Related]
35. Stoma placement in obstructive rectal cancer prior to neo-adjuvant treatment and definitive surgery: A practical guideline.
Vermeer TA; Orsini RG; Nieuwenhuijzen GA; Rutten HJ; Daams F
Eur J Surg Oncol; 2016 Feb; 42(2):273-80. PubMed ID: 26681383
[TBL] [Abstract][Full Text] [Related]
36. Rectal cancer following abdomino-perineal pull-through for imperforate anus.
Ahmed SN; Evans MD; Bose P; Drew P; Beynon J; Davies M
Colorectal Dis; 2012 Jun; 14(6):e363-4. PubMed ID: 22568648
[No Abstract] [Full Text] [Related]
37. Oncological outcomes in extended time intervals betweenpreoperative chemoradiotherapy with capecitabine and surgery inoperable rectal adenocarcinoma.
Muñoz MA; Palacios MG; Malca J; Mantilla R; Montenegro PC; Chavez I
Rev Gastroenterol Peru; 2018; 38(1):9-21. PubMed ID: 29791416
[TBL] [Abstract][Full Text] [Related]
38. [Downstaging after neoadjuvant therapy for rectal cancer modifies the planned original surgery].
Scutari F; Tramutola G; Morlino A; Rossi MT; Manzione L; Rosati G; Sopranzi A
G Chir; 2008; 29(6-7):277-80. PubMed ID: 18544264
[TBL] [Abstract][Full Text] [Related]
39. Global DNA methylation is altered by neoadjuvant chemoradiotherapy in rectal cancer and may predict response to treatment - A pilot study.
Tsang JS; Vencken S; Sharaf O; Leen E; Kay EW; McNamara DA; Deasy J; Mulligan ED
Eur J Surg Oncol; 2014 Nov; 40(11):1459-66. PubMed ID: 25108814
[TBL] [Abstract][Full Text] [Related]
40. Risk-Adapted Adjuvant Chemotherapy After Concomitant Fluoropyrimidine-Radiotherapy Neoadjuvant Treatment for Patients With Resectable CT3-4 or N+ Rectal Cancer: Five-Year Disease-Free Survival Results of a Single-Center Series.
Sastre J; Serrano JJ; Fernández C; Ramirez C; Ortega L; García-Paredes B; Corona J; Alfonso R; Córdoba S; Díaz-Rubio E
Clin Colorectal Cancer; 2016 Jun; 15(2):128-34. PubMed ID: 26385572
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
